Search

everythinglearnresearchcommunity

for

Search:↓

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

New retinoids are effective for various skin conditions and are being developed to have fewer side effects.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Melanoma patients can learn to check their skin, early balding in men may indicate similar risks as PCOS in women, certain criteria can help predict skin cancer behavior, small skin cancer may not need extra therapy after surgery, and sterile gloves don't reduce infection in minor surgeries.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Bald men may have higher heart disease risk.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

Using anabolic-androgenic steroids can cause skin problems like acne and hair loss in athletes.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

Finasteride side effects in young men may be linked to specific gene variations.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Found microRNA differences in hair cells, suggesting potential treatment targets for hair loss.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Estrogen and androgenic hair increase melanoma risk, especially in European-ancestry individuals.

Almost 40% of Greek women with acne show signs of androgen-related disorders, with adult women more likely affected.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Recognizing and managing hirsutism, alopecia, and acne is crucial for improving wellbeing in women with PCOS.

Hair loss in young men in Central India is linked to severe heart disease.